← Eichor
Study identifier: NCT07248735 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of CIMT With and Without Robotic Gloves in Children With Hemiplegic CP

Condition: Child Development Disorder  ·  Sponsor: Riphah International University

PhaseNA
Planned participants34
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersNo

About this study

This study investigates the impact of CIMT, with and without robotic gloves, on hand dexterity and grip strength in children with hemiplegic CP, aiming to enhance motor skills and promote independence in daily activities. Conducted as a randomized controlled trial at DHQ Hospital, Mandi Bahauddin, the study involves two groups of children aged 6-12 with hemiplegic CP. One group of 17 children will receive CIMT alone with standard treatment, while the other 17 will receive CIMT combined with robotic glove assistance. The robotic glove device aids in flexion, extension, and individual finger movements, providing support for both isolated and coordinated finger actions. Each therapy session will last six hours and be held three to five days a week over four to eight weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Imran Amjad, PhD  ·  9233224390125  ·  imran.amjad@riphah.edu.pk

Muhammad Asif Javed, MS-PT  ·  923224209422  ·  a.javed@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Imran AmjadLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07248735